183 related articles for article (PubMed ID: 23384245)
21. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
[TBL] [Abstract][Full Text] [Related]
22. Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.
Feinberg E; Swartz K; Zaslavsky A; Gardner J; Walker DK
Pediatrics; 2002 Feb; 109(2):E29. PubMed ID: 11826239
[TBL] [Abstract][Full Text] [Related]
23. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
[TBL] [Abstract][Full Text] [Related]
24. Racial Disparities in Health Care Utilization at the End of Life Among New Jersey Medicaid Beneficiaries With Advanced Cancer.
Yang A; Goldin D; Nova J; Malhotra J; Cantor JC; Tsui J
JCO Oncol Pract; 2020 Jun; 16(6):e538-e548. PubMed ID: 32298223
[TBL] [Abstract][Full Text] [Related]
25. Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer.
Phelps AC; Maciejewski PK; Nilsson M; Balboni TA; Wright AA; Paulk ME; Trice E; Schrag D; Peteet JR; Block SD; Prigerson HG
JAMA; 2009 Mar; 301(11):1140-7. PubMed ID: 19293414
[TBL] [Abstract][Full Text] [Related]
26. Associations between Mild Cognitive Dysfunction and End-of-Life Outcomes in Patients with Advanced Cancer.
Kurita K; Reid MC; Siegler EL; Diamond EL; Prigerson HG
J Palliat Med; 2018 Apr; 21(4):536-540. PubMed ID: 29298104
[TBL] [Abstract][Full Text] [Related]
27. The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment.
Morshed RA; Reihl SJ; Molinaro AM; Kakaizada S; Young JS; Schulte JD; Butowski N; Taylor J; Bush NA; Aghi MK; Berger MS; Chang S; Clarke J; Hervey-Jumper SL
J Neurooncol; 2020 May; 148(1):131-139. PubMed ID: 32350780
[TBL] [Abstract][Full Text] [Related]
28. Disparities in clinical trial enrollment among patients with gastrointestinal cancer relative to minority-serving and safety-netting hospitals.
Khan MMM; Munir MM; Woldesenbet S; Khalil M; Endo Y; Katayama E; Altaf A; Dillhoff M; Obeng-Gyasi S; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):896-902. PubMed ID: 38555017
[TBL] [Abstract][Full Text] [Related]
29. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer.
Eskander MF; Gil L; Beal EW; Li Y; Hamad A; Oppong B; Obeng-Gyasi S; Tsung A
Ann Surg Oncol; 2022 Feb; 29(2):1271-1277. PubMed ID: 34655352
[TBL] [Abstract][Full Text] [Related]
30. Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.
Abbas A; Diaz A; Obeng-Gyasi S; Cloyd JM; Ejaz A; Stewart JH; Pawlik TM
J Am Coll Surg; 2022 Apr; 234(4):589-598. PubMed ID: 35290279
[TBL] [Abstract][Full Text] [Related]
31. Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.
Hamel LM; Penner LA; Albrecht TL; Heath E; Gwede CK; Eggly S
Cancer Control; 2016 Oct; 23(4):327-337. PubMed ID: 27842322
[TBL] [Abstract][Full Text] [Related]
32. Cancer trial enrollment after state-mandated reimbursement.
Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
[TBL] [Abstract][Full Text] [Related]
33. Impact of Primary Care Physician Interaction on Longitudinal Adherence to Screening Mammography Across Different Racial/Ethnic Groups.
Flores EJ; López D; Miles RC; Glover M; Lehman CD; Harvey HB; Narayan AK
J Am Coll Radiol; 2019 Jul; 16(7):908-914. PubMed ID: 30737162
[TBL] [Abstract][Full Text] [Related]
34. Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young Adults.
Sullenger RD; Deal AM; Grilley Olson JE; Matson M; Swift C; Lux L; Smitherman AB
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):104-110. PubMed ID: 34010032
[No Abstract] [Full Text] [Related]
35. Parental Factors Associated With the Decision to Participate in a Neonatal Clinical Trial.
Weiss EM; Olszewski AE; Guttmann KF; Magnus BE; Li S; Shah AR; Juul SE; Wu YW; Ahmad KA; Bendel-Stenzel E; Isaza NA; Lampland AL; Mathur AM; Rao R; Riley D; Russell DG; Salih ZNI; Torr CB; Weitkamp JH; Anani UE; Chang T; Dudley J; Flibotte J; Havrilla EM; Kathen CM; O'Kane AC; Perez K; Stanley BJ; Wilfond BS; Shah SK
JAMA Netw Open; 2021 Jan; 4(1):e2032106. PubMed ID: 33433595
[TBL] [Abstract][Full Text] [Related]
36. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
[TBL] [Abstract][Full Text] [Related]
37. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
[TBL] [Abstract][Full Text] [Related]
38. A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials.
Carpenter WR; Tyree S; Wu Y; Meyer AM; DiMartino L; Zullig L; Godley PA
Clin Trials; 2012 Aug; 9(4):426-35. PubMed ID: 22761398
[TBL] [Abstract][Full Text] [Related]
39. Disparities in enrollment and use of an electronic patient portal.
Goel MS; Brown TL; Williams A; Hasnain-Wynia R; Thompson JA; Baker DW
J Gen Intern Med; 2011 Oct; 26(10):1112-6. PubMed ID: 21538166
[TBL] [Abstract][Full Text] [Related]
40. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
